News

Patents currently granted cover Europe, the USA, Canada, Japan and India, with more patents in other countries being filed. The portable system has been developed for the treatment

With this expansion, the companies expect to develop and commercialize the HAE drug in Latin America, excluding Mexico and the Caribbean, Taiwan, Singapore and South Korea. Under their

Initially, the company plans to roll out approximately 10-12 eye care pharma products in the metro cities of India by end of July, Pharmabizz reported. Bausch & Lomb‘s

The new patent entitled, ‘Retinal Derivatives and Methods for the Use Thereof for the Treatment of Visual Disorders,’ covers methods of utilizing QLT091001 to treat diseases linked with

Glysom is made from glycine, an amino acid that occurs naturally in the body. It is particularly effective in promoting the deep, non-REM sleep crucial to feeling refreshed

Donepezil Hydrochloride tablets are indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer’s type and fall under the central nervous system (CNS) therapeutic segment.

The orphan drugs status will allow the company to market its recombinant factor VIIa fused with albumin in Europe for a span of 10 years if the product

The company is developing LibiGel as a treatment for female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women. The enrollment of the patients has

Piperacillin and Tazobactam for injection is therapeutically equivalent to Pfizer Injectables’ marketed product, Zosyn. Piperacillin and Tazobactam for injection is indicated for the treatment of patients with moderate